Sprites
Klicken Sie bitte hier, um diesen Artikel jetzt auszudrucken.
15.10.2009 | 22:17
(6 Leser)
PR Newswire · Mehr Nachrichten von PR Newswire

ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26

SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company''s Principal Executive Officer, Brian M. Culley, will present at the BIOCOM Investor Conference on Monday, October 26, 2009, at 10:00 a.m. Pacific time, at the Hyatt Regency in La Jolla, California.

Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals Web site at http://www.adventrx.com/. An archived presentation will be available on the Web site for 30 days.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a specialty pharmaceutical company whose product candidates are designed to improve the safety of existing cancer treatments. More information can be found on the Company''s web site at http://www.adventrx.com/.

ADVENTRX Pharmaceuticals, Inc.

CONTACT: Brian Culley, Principal Executive Officer of ADVENTRX
Pharmaceuticals, +1-858-552-0866; or Investors, Don Markley of
Lippert/Heilshorn & Associates, Inc., +1-310-691-7100, dmarkley@lhai.com, for
ADVENTRX Pharmaceuticals

Web Site: http://www.adventrx.com/


© 2009 PR Newswire

Link: http://www.finanznachrichten.de/nachrichten-2009-10/15212992-adventrx-pharmaceuticals-to-present-at-the-biocom-investor-conference-on-october-26-008.htm